4//SEC Filing
IDENIX PHARMACEUTICALS INC 4
Accession 0001209191-14-050674
CIK 0001093649operating
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 5:37 PM ET
Size
5.6 KB
Accession
0001209191-14-050674
Insider Transaction Report
Form 4
Dumas Jacques
EVP, Chief Scientific Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2014-08-05−250,000→ 0 totalExercise: $7.42Exp: 2024-01-19→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]These options, which vested in 48 equal monthly installments beginning on January 31, 2014, were cancelled pursuant to the Agreement and Plan of Merger between the Issuer and Merck & Co. Inc. in exchange for a cash payment of $17.08 per share, representing the difference between the exercise price of the options and $24.50 per share.
Documents
Issuer
IDENIX PHARMACEUTICALS INC
CIK 0001093649
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001093649
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 5:37 PM ET
- Size
- 5.6 KB